Oarsman Capital Inc. Buys 51 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Oarsman Capital Inc. raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 21.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 286 shares of the company’s stock after purchasing an additional 51 shares during the quarter. Oarsman Capital Inc.’s holdings in HCA Healthcare were worth $86,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the stock. First Eagle Investment Management LLC raised its holdings in shares of HCA Healthcare by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock valued at $1,351,830,000 after purchasing an additional 23,177 shares during the period. Geode Capital Management LLC lifted its position in shares of HCA Healthcare by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock valued at $1,159,882,000 after buying an additional 50,321 shares during the last quarter. Norges Bank acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $840,286,000. Franklin Resources Inc. lifted its holdings in HCA Healthcare by 11.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after purchasing an additional 174,946 shares during the last quarter. Finally, Royal London Asset Management Ltd. raised its position in shares of HCA Healthcare by 62.0% in the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock valued at $450,461,000 after purchasing an additional 574,239 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $332.53 on Friday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock has a market cap of $81.87 billion, a price-to-earnings ratio of 15.14, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a 50 day simple moving average of $327.23 and a 200 day simple moving average of $339.47.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company posted $5.90 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Barclays lowered their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.